OM
Income statement / Annual
Last year (2024), Outset Medical, Inc.'s total revenue was $113.69 M,
a decrease of 12.80% from the previous year.
In 2024, Outset Medical, Inc.'s net income was -$127.98 M.
See Outset Medical, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$113.69 M |
$130.38 M |
$115.38 M |
$102.60 M |
$49.94 M |
$15.08 M |
$2.01 M |
| Cost of Revenue |
$75.13 M
|
$101.38 M
|
$97.54 M
|
$94.99 M
|
$62.97 M
|
$32.88 M
|
$8.12 M
|
| Gross Profit |
$38.56 M
|
$29.00 M
|
$17.83 M
|
$7.61 M
|
-$13.04 M
|
-$17.80 M
|
-$6.12 M
|
| Gross Profit Ratio |
0.34
|
0.22
|
0.15
|
0.07
|
-0.26
|
-1.18
|
-3.05
|
| Research and Development Expenses |
$38.40 M
|
$57.31 M
|
$48.86 M
|
$36.74 M
|
$28.85 M
|
$23.33 M
|
$22.92 M
|
| General & Administrative Expenses |
$43.50 M
|
$45.23 M
|
$40.52 M
|
$36.32 M
|
$30.51 M
|
$8.92 M
|
$6.25 M
|
| Selling & Marketing Expenses |
$70.04 M
|
$96.23 M
|
$89.48 M
|
$65.07 M
|
$45.07 M
|
$20.26 M
|
$11.28 M
|
| Selling, General & Administrative Expenses |
$113.54 M
|
$141.46 M
|
$130.00 M
|
$101.39 M
|
$75.58 M
|
$29.18 M
|
$17.53 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$151.94 M
|
$198.77 M
|
$178.85 M
|
$138.13 M
|
$104.43 M
|
$52.51 M
|
$40.45 M
|
| Cost And Expenses |
$227.06 M
|
$300.15 M
|
$276.39 M
|
$233.12 M
|
$167.40 M
|
$85.39 M
|
$48.57 M
|
| Interest Income |
$9.76 M
|
$10.17 M
|
$3.29 M
|
$498,000.00
|
$526,000.00
|
$2.49 M
|
$1.71 M
|
| Interest Expense |
$23.87 M
|
$12.68 M
|
$3.57 M
|
$1.72 M
|
$2.37 M
|
$4.26 M
|
$4.64 M
|
| Depreciation & Amortization |
$5.73 M
|
$5.81 M
|
$6.28 M
|
$6.18 M
|
$3.76 M
|
$1.94 M
|
$1.49 M
|
| EBITDA |
-$97.89 M |
-$153.79 M |
-$152.81 M |
-$124.86 M |
-$114.85 M |
-$62.09 M |
-$43.62 M |
| EBITDA Ratio |
-0.86
|
-1.18
|
-1.37
|
-1.27
|
-2.35
|
-4.37
|
-21.82
|
| Operating Income Ratio |
-1
|
-1.3
|
-1.4
|
-1.27
|
-2.35
|
-4.66
|
-23.2
|
| Total Other Income/Expenses Net |
-$14.11 M
|
-$2.50 M
|
-$1.64 M
|
-$1.22 M
|
-$4.03 M
|
$2.03 M
|
-$3.19 M
|
| Income Before Tax |
-$127.49 M
|
-$172.27 M
|
-$162.66 M
|
-$131.74 M
|
-$121.49 M
|
-$68.28 M
|
-$49.76 M
|
| Income Before Tax Ratio |
-1.12
|
-1.32
|
-1.41
|
-1.28
|
-2.43
|
-4.53
|
-24.79
|
| Income Tax Expense |
$491,000.00
|
$523,000.00
|
$295,000.00
|
$199,000.00
|
-$794,000.00
|
$20,000.00
|
$25,000.00
|
| Net Income |
-$127.98 M
|
-$172.80 M
|
-$162.96 M
|
-$131.94 M
|
-$120.70 M
|
-$68.30 M
|
-$49.78 M
|
| Net Income Ratio |
-1.13
|
-1.33
|
-1.41
|
-1.29
|
-2.42
|
-4.53
|
-24.8
|
| EPS |
-2.46 |
-3.48 |
-3.38 |
-2.89 |
-2.83 |
-1.61 |
-1.65 |
| EPS Diluted |
-2.46 |
-3.48 |
-3.38 |
-2.89 |
-2.83 |
-1.61 |
-1.65 |
| Weighted Average Shares Out |
$51.95 M
|
$49.59 M
|
$48.16 M
|
$45.59 M
|
$42.72 M
|
$42.33 M
|
$30.08 M
|
| Weighted Average Shares Out Diluted |
$51.95 M
|
$49.59 M
|
$48.16 M
|
$45.59 M
|
$42.72 M
|
$42.33 M
|
$30.08 M
|
| Link |
|
|
|
|
|
|
|
